Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical disease recurrence after definitive local therapy for prostate cancer

Author: McKay Rana R.   Gray Kathryn P.   Hayes Julia H.   Bubley Glenn J.   Rosenberg Jonathan E.   Hussain Arif   Kantoff Philip W.   Taplin Mary-Ellen  

Publisher: Blackwell Publishing

E-ISSN: 1097-0142|121|15|2603-2611

ISSN: 0008-543X

Source: Cancer, Vol.121, Iss.15, 2015-08, pp. : 2603-2611

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract